Adrucil (Generic 5-Fluorouracil): Complete Medication Guide
Key Takeaways
Adrucil is a chemotherapy drug used to treat various cancers, including colorectal, breast, and pancreatic cancers.
Common side effects include nausea, vomiting, mouth sores, and hair loss; serious side effects require immediate medical attention.
Dosage varies widely based on cancer type, body weight, and individual treatment plans created by your oncology team.
Many drug interactions exist, especially with other cancer medications and certain anticoagulants.
Regular monitoring through blood tests and clinical visits is essential during treatment.
Adrucil Overview
Adrucil, known generically as 5-Fluorouracil (5-FU), is a chemotherapy medication used to treat multiple types of cancer. It belongs to a class of drugs called antimetabolites, which work by interfering with cancer cell growth and division. Specifically, 5-FU mimics uracil, a building block of DNA and RNA, and tricks cancer cells into incorporating it into their genetic material. This disruption prevents cancer cells from multiplying and ultimately leads to their death.
Adrucil is commonly prescribed for colorectal cancer, breast cancer, stomach cancer, pancreatic cancer, and certain head and neck cancers. It may be used alone or in combination with other chemotherapy agents and radiation therapy. The drug can be administered intravenously (IV) or topically as a cream for certain skin cancers. Your oncology team will determine the best treatment approach based on your specific cancer type, stage, and overall health status.
Side Effects
Adrucil can cause a range of side effects, from mild to severe. Most side effects are temporary and subside after treatment ends, but some may require medical management. It's important to report any symptoms to your healthcare team promptly.
Common Side Effects
Nausea and vomiting — Often occur within hours of treatment; anti-nausea medications can help manage these symptoms.
Mouth sores (mucositis) — Painful ulcers in the mouth, throat, and digestive tract that may make eating difficult.
Hair loss (alopecia) — Hair thinning or complete baldness, which is usually temporary and reverses after treatment ends.
Diarrhea — Loose stools that may lead to dehydration; maintain fluid intake and inform your doctor if severe.
Fatigue — Extreme tiredness that may persist for weeks; rest and gentle activity can help.
Low blood cell counts — Reduced white blood cells, red blood cells, and platelets, increasing infection and bleeding risk.
Serious Side Effects
Severe infection — Low white blood cell counts increase vulnerability to life-threatening infections; fever above 100.4°F requires immediate attention.
Bleeding or bruising — Low platelet counts may cause unusual bleeding, nosebleeds, or bruising without injury.
Hand-foot syndrome — Redness, swelling, and pain in hands and feet; in severe cases, skin may peel or blister.
Cardiac toxicity — Rare but serious heart rhythm problems or weakened heart function, especially with high doses.
Severe dehydration — Extreme vomiting or diarrhea leading to electrolyte imbalance and organ stress.
When to Seek Medical Attention
Contact your healthcare provider immediately if you experience fever above 100.4°F, severe chest pain, difficulty breathing, uncontrolled bleeding, signs of severe infection, or inability to keep food or fluids down. Don't wait for a scheduled appointment—call your oncology team right away. If symptoms are life-threatening, go to the nearest emergency room or call 911. Your medical team needs to know about all side effects so they can adjust your treatment plan if necessary.
Dosage
Dose Level or Form |
Typical Dose |
Key Detail |
Standard IV bolus |
400–500 mg/m² |
Given as a single injection or over 1–2 minutes; repeated every 3–4 weeks |
Continuous IV infusion |
200–1,000 mg/m² per day |
Delivered over 24–120 hours; often used in combination regimens |
High-dose protocol |
Up to 2,600 mg/m² |
Used in certain cancer types; requires closer monitoring and supportive care |
Topical cream (Efudex) |
5% or 2% concentration |
Applied to skin twice daily for 2–4 weeks for superficial skin cancers |
Hepatic artery infusion |
100–500 mg |
Delivered directly to liver for liver cancers; requires specialized catheter placement |
Important: Never skip doses or stop Adrucil without your oncologist's approval, as this may reduce treatment effectiveness. If you miss an appointment for chemotherapy, contact your oncology team immediately to reschedule. Do not attempt to "catch up" on missed doses on your own. Your doctor may adjust your dose based on how well you tolerate the medication and your blood test results.
Drug Interactions
Adrucil can interact with many medications, potentially increasing side effects or reducing effectiveness. Always inform your oncology team about all medications, supplements, and herbal products you're taking.
Leucovorin (Folinic Acid)
Leucovorin is often given with Adrucil to enhance its anti-cancer effects and reduce certain toxicities. This is an intentional combination, but it requires careful timing and dosing under medical supervision.
Warfarin or Other Blood Thinners
Adrucil may increase the effects of anticoagulants, raising bleeding risk. Your doctor will monitor your blood clotting ability closely and may adjust your blood thinner dose.
Methotrexate
Combined use may increase toxicity to bone marrow and other tissues. This combination requires careful monitoring and dose adjustment by your oncology team.
Phenytoin (Dilantin)
Adrucil may reduce phenytoin levels, potentially decreasing seizure control. Blood level monitoring and dose adjustments may be necessary.
Immunosuppressive Drugs
Adrucil already lowers immune function; combining it with other immunosuppressants increases infection risk significantly.
Other Chemotherapy Agents
Combining Adrucil with other cancer drugs (like doxorubicin, irinotecan, or cisplatin) may increase toxicity and require dose adjustments and enhanced monitoring.
Continue Learning
Related articles you might find helpful
Pros and Cons
Pros
Highly effective against multiple cancer types, including colorectal, breast, stomach, and pancreatic cancers.
Generic formulation available, making treatment more affordable for many patients.
Can be combined with other therapies (chemotherapy, radiation, targeted drugs) for enhanced effectiveness.
Decades of clinical experience and established treatment protocols minimize uncertainty.
Manageable side effects in most cases, with supportive medications available to reduce nausea, fatigue, and other symptoms.
Cons
Significant and sometimes severe side effects, including hair loss, mouth sores, nausea, and low blood cell counts.
Requires frequent IV infusions or topical application, demanding time commitment and travel to treatment centers.
Regular blood tests and clinic visits are mandatory to monitor safety and adjust treatment.
Risk of serious complications like infection, bleeding, and cardiac problems, especially with prolonged use.
Hair loss and other visible side effects can impact quality of life and emotional wellbeing during treatment.
Frequently Asked Questions
Get answers to common questions about Adrucil.
Most Adrucil is eliminated within 12–24 hours after IV infusion, though a small amount may persist longer in tissues. Your body metabolizes the drug primarily in the liver and excretes it through urine. However, the effects of Adrucil on cancer cells and normal tissues can last longer than the drug itself remains detectable in blood tests.
Hair loss from Adrucil is usually temporary and reverses within 3–6 months after treatment ends. The hair follicles are typically not permanently damaged. However, regrowth speed varies by individual. Some patients experience thinner or slightly different texture upon regrowth. Wearing a wig, scarf, or hat during treatment can help manage appearance concerns.
Focus on small, frequent meals with soft, bland foods that are easy to swallow, especially if you have mouth sores. Stay hydrated by drinking plenty of water, broths, and non-citrus juices. Avoid spicy, hot, acidic, or hard foods that can irritate your mouth. Protein-rich foods like yogurt, eggs, and smoothies support healing. Ask your oncology team or a dietitian for personalized nutrition guidance.
Adrucil is the brand name for 5-fluorouracil (5-FU); generic versions contain the same active ingredient. Different formulations (IV infusion, topical cream, continuous infusion) may have different names (like Efudex for topical 5-FU), but the active drug is identical. Your doctor chooses the formulation best suited to your cancer type and treatment plan.
Alcohol can increase nausea, dehydration, and liver toxicity during Adrucil treatment. It's best to avoid or severely limit alcohol consumption while undergoing chemotherapy. Discuss safe alcohol use with your oncology team, as some patients may tolerate small amounts while others should abstain completely. Stay hydrated with non-alcoholic beverages instead.
The Bottom Line
Adrucil (5-Fluorouracil) is a powerful chemotherapy medication that has helped millions of cancer patients achieve remission and improve survival rates. While side effects can be challenging, they're often manageable with proper medical support and preparation. Your oncology team will closely monitor your response to treatment and adjust your care plan as needed. Understanding what to expect—from common side effects to serious warning signs—empowers you to advocate for yourself and report concerns early. This information is educational and does not replace advice from your healthcare provider.
Doctronic's AI Doctor is the first legally authorized to practice medicine, having completed 22 million consultations with 99.2% treatment alignment with physicians. If you have additional questions about Adrucil, cancer treatment options, or medication management, Doctronic offers free AI consultations, plus affordable video visits ($39) and text visits ($19) with licensed healthcare providers available 24/7 with a 4-minute average wait. All consultations are HIPAA compliant and anonymous by default.
